A Pharmacokinetic Study Comparing EG12014 and Herceptin (Trastuzumab) in Healthy Male Volunteers
Clinical trial NCT03180242 · COMPLETED
Trial details
- NCT number
- NCT03180242
- Sponsor
- EirGenix, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-22
- Primary completion
- 2016-08-22
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.